Results 241 to 250 of about 299,603 (337)
MiR‐221‐3p Attenuates IL‐33‐Induced Mast Cell Cytokine Expression by Targeting KIT
ABSTRACT Background Mast cells (MCs) are involved in type 2 inflammation in chronic rhinosinusitis with nasal polyps (CRSwNP), which depends on interleukin (IL)‐33 stimulation. MiR‐221 is reported to be an important regulator of MCs, and miR‐221‐3p can be expressed in CRSwNP. However, the role of miR‐221‐3p in CRSwNP is unclear. Methods Ethmoid tissues
Ruowu Liu+11 more
wiley +1 more source
Global differences and risk factors influencing drug hypersensitivity quality of life: A multicenter, multiethnic study of drug allergy across 3 continents. [PDF]
Copaescu AM+5 more
europepmc +1 more source
ABSTRACT Background Chronic rhinosinusitis with nasal polyps (CRSwNP) significantly impacts patients’ quality of life (QoL). Standard treatments include nasal irrigations, nasal steroids, systemic corticosteroids, and functional endoscopic sinus surgery (FESS).
Anne‐Sophie Homøe+7 more
wiley +1 more source
When leuprolide acetate is essential to care: A review of the literature and framework for assessing drug allergy. [PDF]
Belmont AP+4 more
europepmc +1 more source
Is there a connection between drug allergy and exotoxins?
Lyudmila Akhmaltdinova
openalex +2 more sources
ABSTRACT Background The pathogenesis of inflammation in eosinophilic chronic rhinosinusitis (ECRS) and non‐eosinophilic chronic rhinosinusitis (NECRS) remains poorly understood. This study aimed to assess immune cell infiltration within the sinonasal microenvironment in these conditions.
Katarzyna Czerwaty+5 more
wiley +1 more source
Dendrimeric Antigens for Drug Allergy Diagnosis: A New Approach for Basophil Activation Tests [PDF]
Noemí Molina+9 more
openalex +1 more source
Watching the Barn Door Open—Timing CML Stem Cell Allografts
American Journal of Hematology, EarlyView.
Jeffrey H. Lipton
wiley +1 more source
ABSTRACT Background Temperature‐controlled radiofrequency (TCRF) ablation of the posterior nasal nerve has been shown to improve chronic rhinitis (CR) symptoms and quality of life (QoL). This study assesses the durability of TCRF's effectiveness and safety 3 years post‐procedure in patients with perennial allergic CR and nonallergic CR.
J. Pablo Stolovitzky+8 more
wiley +1 more source